Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Christopher Brown und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Temporal Lobe, Gray Matter, Positron-Emission Tomography. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Typical MRI measures of neurodegeneration have limited sensitivity in early disease stages. Diffusion MRI (dMRI) microstructural measures may allow for detection in preclinical stages. METHODS Participants had dMRI and either beta‐amyloid PET or plasma biomarkers of Alzheimer's pathology within 18 months of MRI. Microstructure was measured in portions of the medial temporal lobe (MTL) with high neurofibrillary tangle (NFT) burden based on a previously developed post mortem 3D‐map. Regressions examined relationships between microstructure and markers of Alzheimer's pathology in preclinical disease and then across disease stages. RESULTS There was higher isometric volume fraction in amyloid‐positive compared to amyloid‐negative cognitively unimpaired individuals in high tangle MTL regions. Similarly, plasma biomarkers and 18 F‐flortaucipir were associated with microstructural changes in preclinical disease. Additional microstructural effects were seen across disease stages. DISCUSSION Combining a post mortem atlas of NFT pathology with microstructural measures allows for detection of neurodegeneration in preclinical Alzheimer's disease. Highlights Typical markers of neurodegeneration are not sensitive in preclinical Alzheimer's. dMRI measured microstructure in regions with high NFT. Microstructural changes occur in medial temporal regions in preclinical disease. Microstructural changes occur in other typical Alzheimer's regions in later stages. Combining post mortem pathology atlases with in vivo MRI is a powerful framework.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Siemens Healthineers, Digital Technology and Innovation, Princeton, New Jersey, USA.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Christopher Brown
Förderung
- NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Brown, C., Das, S., Xie, L., Nasrallah, I., Detre, J., Chen-Plotkin, A., Shaw, L., McMillan, C., Yushkevich, P., & Wolk, D. (2024). Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13832
Vancouver
Brown C, Das S, Xie L, Nasrallah I, Detre J, Chen-Plotkin A, et al. Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13832
BibTeX
@article{Brown2024,
author = {Brown, Christopher and Das, Sandhitsu and Xie, Long and Nasrallah, Ilya and Detre, John and Chen-Plotkin, Alice and Shaw, Leslie and McMillan, Corey and Yushkevich, Paul and Wolk, David},
title = {Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13832}
}
EUVIMED